We are live on
!
Find out more
VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $29.9M | – | – | – |
|
|
O
2
OrbiMed
New York
| $25M | – | – | – |
|
|
NMC
3
NEA Management Company
Timonium,
Maryland
| $24.4M | – | – | – |
|
|
VP
4
venBio Partners
San Francisco,
California
| $17.5M | – | – | – |
|
|
NHAS
5
Novo Holdings A/S
Hellerup,
Denmark
| $14.8M | – | – | – |
|
|
FCMI
6
Foresite Capital Management III
Larkspur,
California
| $11.3M | +$533K | +36,870 | +7% |
|
|
TCM
7
Tekla Capital Management
Boston,
Massachusetts
| $5.5M | – | – | – |
|
|
PC
8
Polar Capital
London,
United Kingdom
| $2M | +$70.1K | +4,851 | +5% |
|
|
PA
9
Perceptive Advisors
New York
| $1.12M | -$2.08M | -143,832 | -72% |
|
10
US Bancorp
Minneapolis,
Minnesota
| $77K | +$55.5K | +3,840 | New |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $34K | +$15.9K | +1,101 | +184% |
|
12
UBS Group
Zurich,
Switzerland
| $14K | +$10.1K | +702 | +70,200% |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $9K | +$6.79K | +470 | New |
|
14
Morgan Stanley
New York
| $4K | +$2.69K | +186 | +1,240% |
|